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Acute pancreatitis (AP) is a common abdominal inflammatory disorder and one of the 
leading causes of hospital admission for gastrointestinal disorders. No specific pharma-
cological or nutritional therapy is available but highly needed. Inulin-type fructans (ITFs) 
are capable of modifying gut immune and barrier homeostasis in a chemistry-dependent 
manner and hence potentially applicable for managing AP, but their efficacy in AP has not 
been demonstrated yet. The current study aimed to examine and compare modulatory 
effects of ITFs with different degrees of fermentability on pancreatic–gut immunity and 
barrier function during experimentally induced AP in mice. BALB/c mice were fed short 
(I)- or long (IV)-chain ITFs supplemented diets for up to 3 days before AP induction by 
caerulein. Attenuating effects on AP development were stronger with ITF IV than with ITF 
I. We found that long-chain ITF IV attenuated the severity of AP, as evidenced by reduced 
serum amylase levels, lipase levels, pancreatic myeloperoxidase activity, pancreatic 
edema, and histological examination demonstrating reduced pancreatic damage. Short-
chain ITF I demonstrated only partial protective effects. Both ITF IV and ITF I modulated 
AP-associated systemic cytokine levels. ITF IV but not ITF I restored AP-associated 
intestinal barrier dysfunction by upregulating colonic tight junction modulatory proteins, 
antimicrobial peptides, and improved general colonic histology. Additionally, differential 
modulatory effects of ITF IV and ITF I were observed on pancreatic and gut immunity: ITF 
IV supplementation prevented innate immune cell infiltration in the pancreas and colon 
and tissue cytokine production. Similar effects were only observed in the gut with ITF I and 
not in the pancreas. Lastly, ITF IV but not ITF I downregulated AP-triggered upregulation 
of IL-1 receptor-associated kinase 4 (IRAK-4) and phosphor-c-Jun N-terminal kinase 
(p-JNK), and a net decrease of phosphor-nuclear factor kappa-light-chain-enhancer of 
activated B cells (NF-κB) p65 (p-NF-κB p65) nuclear translocation and activation in the 
pancreas. Our findings demonstrate a clear chain length-dependent effect of inulin on 
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AP. The attenuating effects are caused by modulating effects of long-chain inulin on 
the pancreatic–gut immunity via the pancreatic IRAK-4/p-JNK/p-NF-κBp65 signaling 
pathway and on prevention of disruption of the gut barrier.
Keywords: dietary fibers, inflammation, pancreatic–intestinal immunity, signaling kinases, tight junction proteins, 
antimicrobial peptides
inTrODUcTiOn
Acute pancreatitis (AP) is a sudden inflammation of the pancreas 
caused by inappropriate activation of local digestive enzymes. 
During the past decades, it has become the leading cause of hos-
pital admission for gastrointestinal disorders in many countries 
and the worldwide incidence is increasing (1). Although the mild 
form of AP is self-limited, nearly 20–25% of patients with AP 
develop severe symptoms with systemic inflammatory responses. 
The mortality rate in these patients is as high as 30% (2). Up to 
now, a targeted pharmacological or nutraceutical therapy specific 
for AP management is lacking (3, 4). Novel insight however in 
function–effector relationship of dietary components and their 
anti-inflammatory effects has generated optimism about the pos-
sibility to create nutraceutical strategies to control local inflam-
mation and prevent systemic complications of AP (2).
Pathophysiological studies of AP have revealed that AP is 
caused by unregulated intra-acinar activation of trypsin and 
other digestive enzymes, leading to autodigestion of the pancreas 
and local inflammation. The main triggering factors include 
pancreatic hyperstimulation, gallstones, and alcohol abuse (5). 
The induced local inflammation is accompanied by activation of 
endothelial cells and transendothelial migration of leukocytes, 
neutrophils, and macrophages, leading to release of harmful 
enzymes and cytokines that amplify the local inflammatory 
responses. As a consequence, pancreatic complications such as 
acinar cell necrosis, pseudocyst formation, and abscess develop-
ment might occur in most severe cases, leading to transmission 
of inflammation to other remote organs, which is ultimately 
responsible for AP-associated mortality.
Innate immune activation and acinar cell inflammatory 
signaling play a pivotal role in the pathogenesis of AP (5–8). 
Local inflammation is initiated by acinar cell damage and local 
production of pro-inflammatory cytokines/chemokines by these 
cells, followed by infiltration of neutrophils and macrophages 
(9). Neutrophils, macrophages, and dendritic cells with distinct 
cell-surface and intracellular markers have been associated 
with the development of AP and severity of the inflammatory 
conditions (10–13). The balance between pro-inflammatory and 
Abbreviations: AP, acute pancreatitis; AMPs, antimicrobial peptides; ANOVA, 
analysis of variance; CRAMP, cathelicidin-related antimicrobial peptide; DEFB1, 
β-defensin-1; DP, degree of polymerization; ERK, extracellular signal-regulated 
kinase; H&E, hematoxylin and eosin; IL, interleukin; IRAK, IL-1 receptor 
associated kinase; ITF, inulin-type fructan; JNK, c-Jun N-terminal kinase; LMP, 
low-methoxyl pectins; MAPKs, mitogen-activated protein kinases; MPO, myelop-
eroxidase; NF-κB, nuclear factor kappa-light-chain-enhancer of activated B cells; 
RT-qPCR, real-time quantitative polymerase chain reaction; SCFAs, short-chain 
fatty acids; TAK, TGF-β activated kinase; TGF-β, transforming growth factor-β; TJ, 
tight junction; TNF-α, tumor necrosis factor-α; ZO-1, zonula occludens-1.
anti-inflammatory mediators produced from acini and infiltrated 
immune cells determines the outcome of the AP. Tumor necrosis 
factor (TNF)-α, interleukin (IL)-1, and IL-10 are important 
cytokines in AP (11, 14–16). TNF-α is released by local Ly6Chi 
monocytes/macrophages in the pancreas and enhances the sever-
ity of the experimental disease (11, 17, 18). Regulatory cytokines, 
such as IL-10, limit the local and systemic consequences of experi-
mental pancreatitis (18). Expression of these cytokines is under 
the control of the transcription factor NF-κB. NF-κB activation 
in pancreatic acinar cells is responsible for the expression of a 
large number of inflammation-related genes (19). NF-κB activa-
tion is regulated by its upstream signaling kinases, such as MAP 
kinases (MAPKs), which may be activated by receptor-associated 
kinases, such as IL-1 receptor-associated kinase 4 (IRAK-4) and 
transforming growth factor-β activated kinase (TAK) (20, 21). 
Consequently, modulation of immune cell activation, inflamma-
tory cytokine production, and pancreatic inflammatory signaling 
molecules may be rational approaches to alleviate AP symptoms.
Accumulating evidence is available demonstrating that severe 
AP is associated with changes in the microcirculation, gut 
permeability/motility, bacterial translocation, and activation of 
the gut-associated lymphoid tissue. Preventing AP-associated 
intestinal barrier disruption or inflammation might therefore be 
a key target for effective therapy (22). A possible nutraceutical 
approach to prevent intestinal barrier disruption is by intervening 
with anti-inflammatory food components such as specific dietary 
fibers. Dietary fibers may be fermented by the gut microbiota to 
produce health-promoting short-chain fatty acids (SCFAs) and 
modify intestinal barrier function (23). Therefore, consumption 
of dietary fibers represents a promising strategy to modulate 
the progression of AP. We have recently demonstrated that low-
methoxyl lemon pectin (LMP) attenuated inflammatory responses 
and improved intestinal barrier integrity in experimental AP (2). 
Another family of nutritional molecules with supporting effect 
on barrier function and anti-inflammatory effect that might 
be instrumental for management of AP is inulin-type fructans 
(ITFs) (23–27). ITFs are a family of dietary fibers belonging to 
beta(2→1) linear fructan-type carbohydrate subgroup and have 
an impact on gastrointestinal functions, which is largely related 
to their biochemical and physiological attributes. In the gut, 
ITFs are rapidly fermented to produce SCFAs that exert some 
of the local and systemic effects of ITFs. In addition, ITFs have 
demonstrated clear chemistry or degree of polymerization (DP)-
dependent effects (28). Previous studies have demonstrated that 
DP or chain length of ITFs that affects the magnitude of receptor 
activation and/or their site of fermentation in the gut determines 
their prebiotic and immune modulatory effects on immune cells, 
gut barrier function, and microbiota composition (23–27, 29). 
ITFs have been implicated in a variety of inflammatory and 
TaBle 1 | Different groups of animals with their corresponding diet used in this 
study.
group Diet
Control Normal diet without AP
AP Normal diet with AP
ITF IV + AP 5% ITF IV (in normal diet, w/w) with AP
ITF I + AP 5% ITF I (in normal diet, w/w) with AP
AP, acute pancreatitis; ITF IV, inulin-type fructan IV (long-chain inulins); ITF I, inulin-type 
fructan I (short-chain inulins).
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immunological dysfunctions. However, their potential effects 
have not been studied in the management of AP.
In this study, we examined and compared the effects of long-
chain ITF IV and the more readily fermentable short-chain ITF 
I on their protective effects during experimentally induced AP. 
In a caerulein-induced AP mice model, we studied after ITF 
treatment severity of pancreatitis, the frequencies of infiltrating 
neutrophils, macrophages, and dendritic cells in the pancreas 
and colon as well as production of the cytokines TNF-α, IL-1β, 
and IL-10. Additionally, we studied colon integrity by determin-
ing expression of gut–epithelial tight junction (TJ) modulatory 
proteins and barrier reinforcing immunomodulatory antimi-
crobial peptides (AMPs). Finally, we investigated the signaling 
pathways and kinases modulated by ITFs to gain insight in the 
mechanisms by which ITFs modulate AP.
MaTerials anD MeThODs
Fibers and structural characterization
The applied ITF I (frutalose OFP, 2 <  DP <  25) and ITF IV 
(FrutafitTEX, 10 < DP < 60) were extracted from chicory roots 
(Sensus B.V., Roosendaal, The Netherlands). Their specific chain 
length profiles (range and distribution) were characterized by 
high-performance anion exchange chromatography as previously 
described (23, 24).
animals
All animal-related experimental protocols were approved by the 
Institutional Animal Ethics Committee of Jiangnan University in 
compliance with the recommendations of national and interna-
tional guidelines for the Care and Use of Laboratory Animals, and 
were performed in accordance with the guidelines therein. Eight-
week-old female BALB/c mice, 20 ± 2 g (Su Pu Si Biotechnology, 
Suzhou, Jiangsu, China) reared on ad-libitum access to standard 
laboratory chow and water were used in this study. The animals 
were maintained at Animal Housing Unit of the University under 
controlled temperature (23–25°C), pathogen-free conditions, 
and at a 12:12 h light:dark cycle.
experimental Design and aP induction
One-week time was allowed for the acclimatization of animals 
before starting the experiment(s). Mice were randomly divided 
into four groups (n = 4–6) according to different diets and fed 
for 72 h (Table 1).
After 12  h of fasting, AP was induced in mice by eight 
repeated intraperitoneal (i.p.) injections of caerulein (50 µg/kg/h) 
(Sigma-Aldrich, St. Louis, MO, USA). The littermates in control 
group were injected (i.p.) with the same volume of normal saline 
and served as controls.
Tissues sampling
Mice were euthanized and sacrificed with a lethal dose of 
pentobarbitone sodium (100 mg/kg) 1 h after the last caerulein 
injection. For serum analysis, blood samples were centrifuged at 
3,000 × g for 15 min, after which serum was collected and stored 
at –80°C. Tissues, including pancreas and colon, were excised, 
fixed in 4% paraformaldehyde or snap freeze in liquid nitrogen 
and stored at –80°C for later analysis.
serum amylase and lipase Measurements
Serum amylase activities were measured by a serum assay kit 
(Jian Cheng Bioengineering Institute, Nanjing, China) (30). Lip-
ase activities were measured by enzyme-linked immunosorbent 
assay (ELISA) kits (R&D Systems, Minneapolis, MN, USA).
edema and Myeloperoxidase (MPO) 
activity Measurement
A portion of freshly harvested pancreatic tissue was trimmed 
of fat and weighed. Pancreatic water contents were evaluated 
by the ratio of initial weight (wet weight) of the pancreas to its 
weight after drying at 80°C for 48 h (dry weight). MPO activity 
measurements were determined by an MPO assay kit (Jian Cheng 
Bioengineering Institute, Nanjing, China).
histological evaluation
Fresh pancreatic and colonic tissues were fixed in 4% para-
formaldehyde overnight, washed with ddH2O, and rehydrated 
with ethanol and embedded in paraffin. The Skiving machine 
Slicer PM2245 (Leica, Wetzlar, Germany) diced 5-µm sections 
were stained with hematoxylin and eosin (H&E). For pancreatic 
injury evaluation, a DM2000 light microscope (Leica, Wetzlar, 
Germany) was used at ×40 magnification. The examination was 
carried out based on both infiltrating inflammatory cells and 
other morphological changes in tissues which are considered to 
be markers of inflammation/tissue damage.
elisa analysis
The levels of cytokines (TNF-α, IL-1β, and IL-10) in serum were 
measured by ELISA kits (R&D Systems, Minneapolis, MN, USA) 
following the standard procedure of the manufacturer. To meas-
ure the cytokines level of pancreatic and colonic tissues (TNF-α, 
IL-1β, and IL-10), the tissues were homogenized in a saline 
solution (1:19, w/v) using a Polytron homogenizer (Scientz-48, 
Ningbo, Zhejiang, China) at 55 Hz for 1 min. Samples were cen-
trifuged at 4°C, 10,000 × g for 10 min. Finally, the supernatant was 
collected for ELISA analysis.
rna isolation and real-time Quantitative 
Polymerase chain reaction (rT-qPcr) 
analysis
Transcription of mRNA of occludin, zonula occludens protein-1 
(ZO-1), β-defensin-1 (DEFB1), and cathelicidin-related antimicrobial 
TaBle 2 | List of primers used for RT-qPCR.






DEFB1, β-defensin-1; CRAMP, cathelicidin-related antimicrobial peptide; RT-qPCR, 
real-time quantitative polymerase chain reaction.
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peptide (CRAMP) was analyzed by RT-qPCR. Total RNA was 
isolated from pancreas and colonic tissues using TRIzol (Life 
Technologies, MA, USA) and was subjected to reverse transcrip-
tion using Prime-Script RT reagent kit (TaKaRa Bio, Japan) fol-
lowing the manufacturer’s instructions. SYBR® Green RT-qPCR 
was performed using real-time PCR system (BIO RAD CFX 
Connect, CA, USA). The relative mRNA levels were normalized 
to mRNA levels of β-actin (housekeeping control) and calcula-
tions for fold change of each mRNA were made on comparative 
cycle threshold method (2−ΔΔCt). The primers used in this study 
are provided in Table 2.
Western Blot analysis
Pancreatic and colonic tissues were homogenized in ice-cold lysis 
buffer RIPA (containing cocktail protease inhibitors; Beyotime, 
Shanghai, China). Samples were centrifuged at 4°C, 10,000 × g for 
10 min and equal amounts of protein (30 µg), as determined using 
standard bicinchoninic acid assay (BCA) method by BCA Protein 
Assay Kit (Beyotime, Shanghai, China). Samples were electro-
phoresed on blots 10% sodium dodecyl sulfate polyacrylamide gel 
electrophoresis gel and transferred to polyvinylidene difluoride 
membranes. Membranes were blocked with blocking buffer for 
1.5 h at room temperature, washed with TBS-Tween 20 (TBST), 
and finally incubated overnight at 4°C with anti-extracellular 
signal-regulated kinase (ERK)/phospho-ERK, JNK/phospho-
JNK, p38/phospho-p38, IRAK-4, phospho-p65, and GAPDH 
(housekeeping) antibodies. Incubation with fluorescently labeled 
secondary horseradish peroxidase (HRP)-conjugated secondary 
antibodies (1:3,000) was performed for 2 h at room temperature 
and immunoreactivity was analyzed by Western Lightening Plus 
enhanced chemiluminescence (PerkinElmer, MA, USA) accord-
ing to the manufacturer’s instructions.
Flow cytometry analysis
Freshly harvested pancreatic and colonic tissues were digested 
in 1.0 mg/mL collagenase-P (Boehringer, Mannheim, Germany) 
solution at 37°C for 15  min and filtered through 75  µm filters 
with hank’s solution (Beyotime, Shanghai, China). Single-cell 
suspensions were incubated for 30 min at 4°C in hank’s solution 
with the following mAbs: APC Rat Anti-Mouse CD11b, BV421 
Rat Anti-Mouse F4/80, Alexa Fluor 700 Rat Anti-Mouse Ly-6G, 
PE Hamster Anti-Mouse CD11c, FITC Rat Anti-Mouse MHCII, 
and PerCP-Cy5.5 Rat Anti-Mouse CD8a (BD Pharmingen, CA, 
USA). Gating method of fluorescence-activated cell sorting was 
programmed as CD11b+ Ly-6G+ (for neutrophils), CD11b+ F4/80+ 
(for macrophages), CD11c+ MHCII+ (for conventional dendritic 
cells, cDCs), and CD8a+CD11c+ MHCII+ (for plasmacytoid 
dendritic cells, pDCs). Flow cytometer was performed on Attune 
NxT (Thermo Fisher Scientific, MA, USA). Data were analyzed 
using ACEA NovoExpress software (Novo Express International, 
Inc., South San Francisco, CA, USA).
statistical analysis
Data are expressed as means ± SEM. The parametric distribution 
of the results was confirmed using Kolmogorov–Smirnov test. 
Statistical analysis was performed by one-way analysis of variance 
(ANOVA) followed by Tukey’s post hoc test using GraphPad Prism 
(version 5; GraphPad Software Inc., San Francisco, CA, USA). 
The values of P < 0.05 were considered to indicate a statistically 
significant difference.
resUlTs
iTF iV supplementation of the  
Diet alleviates severity of  
caerulein-induced aP
Modulatory effects of ITFs were examined in caerulein hyper-
stimulated mice by supplementing the diets with either ITF I or 
ITF IV for 3  days before AP induction. While dietary supple-
mentation with 5% ITF I or ITF IV alone without AP induction 
did not show any effect on pancreatic markers (Figure S1 in 
Supplementary Material), protective effects of ITF supplementa-
tion on AP were observed and the effects were highly ITF chain 
length dependent. ITF IV had more attenuating effects than ITF 
I. ITF IV but not ITF I attenuated caerulein-induced increases 
in serum amylase, serum lipase, pancreatic MPO activities, and 
edema (Figures 1A–D). However, both ITF I and ITF IV modu-
lated serum cytokines. Both types of ITFs reduced serum pro-
inflammatory IL-1β levels and increased the regulatory cytokine 
IL-10 (Figures  1E,F). Histological examination of pancreatic 
sections confirmed an overall better attenuating AP effect of 
ITF IV as evidenced by generally improved cellular morphology, 
restored interlobular space expansion, reduced inflammatory 
infiltrates, and acini necrosis (Figure 1G). Taken together, these 
data indicate that ITF-IV-supplemented diets alleviate the sever-
ity of AP in mice, while ITF I diet has a more minor beneficial 
effect.
iTF iV but not iTF i supplementation 
strengthening intestinal Barrier Function 
by Upregulating TJ Proteins and aMPs
Compromised intestinal barrier integrity and intestinal injury, 
marked by dysregulated expression of TJ modulatory proteins 
and barrier reinforcing AMPs, develop as AP progresses 
(22, 31). Therefore, maintaining intestinal barrier function 
might be key in the ITF-induced attenuating effects on AP. 
To determine such an effect of ITFs, we measured in ITF-treated 
animals, the mRNA expression of major structural proteins 
such as TJ, occludin and ZO-1, as well as AMPs DEFB1 and 
CRAMP. All these molecules are involved in the physical and 
chemical barriers of the mucosa (32, 33). The RT-qPCR analysis 
FigUre 1 | ITF IV attenuating the severity of AP. Mice were fed with 5% ITF I or ITF IV supplemented diets for 72 h before AP induction by caerulein. Serum amylase 
(a), serum lipase (B), pancreatic edema (c), MPO activity (D), serum IL-1β (e), and IL-10 levels (F) were then determined as described in Section “Materials and 
Methods,” respectively. Representative photographs showed histomorphology of pancreatic tissues by H&E staining for the indicated groups (bar = 50 µm) and 
pancreatitis histopathologic score (g). Data shown are means ± SEM. *P < 0.05, **P < 0.01, and ***P < 0.001. AP, acute pancreatitis; H&E, hematoxylin and eosin; 
IL, interleukin; ITF, inulin-type fructans; MPO, myeloperoxidase.
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showed that ITF IV but not ITF I supplementation prevented 
caerulein-induced downregulation of occludin and ZO-1 as well 
as the downregulation of DEFB1 and CRAMP (Figures 2A–D). 
Furthermore, histological examination of colon sections 
revealed that intestinal mucosal epithelia widened and villous 
apical epithelium peeled off in mice with AP as compared with 
control mice. This colonic damage was less severe in mice fed on 
ITF IV supplemented diet (Figure 2E). Together, these findings 
suggest that ITF IV but not ITF I supplementation prevents 
AP-associated gut integrity damage and injury.
FigUre 2 | ITF IV upregulating TJ proteins and AMPs in the colon. Mice were fed with 5% ITF I or ITF IV supplemented diets for 72 h before AP induction by 
caerulein. The mRNA levels of TJ proteins occluding (a), ZO-1 (B), DEFB1 (c), and CRAMP (D) in the colon were then determined by RT-qPCR analyses. 
Representative photographs showed histomorphology of colonic tissues (50 µm) by H&E staining (e). Data shown are means ± SEM. *P < 0.05, **P < 0.01, and 
***P < 0.001. AMPs, antimicrobial peptides; AP, acute pancreatitis; CRAMP, cathelicidin-related antimicrobial peptide; DEFB1, β-defensin-1; H&E, hematoxylin and 
eosin; ITF, inulin-type fructans; RT-qPCR, real-time quantitative polymerase chain reaction; SEM, standard error of mean; TJ, tight junction; ZO-1, zonula occludens-1.
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iTF iV supplementation reducing innate 
immune cell infiltration into the Pancreas 
and Pancreatic cytokine Production 
during aP
Both infiltration of inflammatory immune cells and an imbalance 
between pro-inflammatory and anti-inflammatory cytokines are 
key immunological pathophysiological events in AP develop-
ment (34–36). For this reason, we determined the frequencies 
of neutrophils (CD11b+Ly-6G+), macrophages (CD11b+F4/80+), 
cDCs (CD11c+MHCII+), and pDCs (CD8a+ CD11c+MHCII+) 
that infiltrated into the pancreas of AP mice fed with ITFs. ITF IV 
supplementation profoundly inhibited the infiltration of neutro-
phils and macrophages (Figure S2 in Supplementary Material). 
The percentage of CD8a+ DCs or pDCs but not cDCs was lowered 
with AP but normal in mice fed with ITF IV. ITF I did not have 
such an effect (Figure S2 in Supplementary Material). The per-
centages of neutrophil and macrophage in the pancreas robustly 
increased with AP induction and were significantly less in mice 
fed with ITF IV (Figures 3A–C) but this was still increased in 
mice fed with ITF I. Additionally, pancreatic cytokine production 
remained enhanced in ITFI but not in animals fed with ITF IV 
(Figure  3D). Collectively, these data demonstrate the immune 
attenuating effects of ITF IV.
Both iTF iV and iTF i supplementation 
Modulating aP-induced innate immune 
cell infiltration in the gut and cytokine 
Production
Immune compromised gut environment as a result of disrupted 
barrier function and intestinal injury is associated with major 
inflammatory cell infiltration and imbalanced inflammatory 
cytokine production. Therefore, we also investigated infiltration 
of innate immune cells in the gut during AP. AP induction resulted 
in robust increases in neutrophils and macrophages in the colon. 
Both ITF I and ITF IV supplementation reduced the number of 
infiltrating neutrophils and macrophages (Figures  4A–C). The 
percentage of CD8a+ DCs or pDCs in the colon lowered with 
AP, but was prevented by ITF IV and not by ITF I (Figure S3 in 
Supplementary Material). Furthermore, consistent with reduced 
inflammatory cell infiltration in the gut, both ITFs prevented 
AP-induced increases in pro-inflammatory TNF-α and IL-1β 
levels, and decreases in IL-10 level in the colon as compared 
with untreated AP control (Figure  4D). Taken together, these 
data suggest positive immunomodulatory effects of both ITFs on 
AP-associated gut inflammation.
iTF iV but not iTF i supplementation 
Modulating Pancreatic iraK-4/JnK/nF-κB 
activation in aP
Lastly, we investigated the signaling molecular pathways under-
lying differential effects by ITF I and ITF IV supplementation. 
Activation of NF-κB and its upstream signaling kinases (IRAK, 
TAK1, and MAPKs) were determined by Western blot. It was 
found that ITF IV significantly modulated AP-induced IRAK-4, 
JNK, and NF-κB activation, while p-TAK, p-ERK, and p-p38 
remained unaffected by ITF (Figures  5A–D). In comparison, 
ITF I attenuated IRAK-4 and p-JNK activation associated with 
AP, but did not affect NF-κB nuclear translocation and activation 
(Figures 5A–D).
DiscUssiOn
The current study examines and compares effects of different types 
of ITFs in experimental AP and associated intestinal immune and 
barrier dysregulation. The effects were ITF type dependent and 
more pronounced with ITF IV than with ITF I. We observed that 
dietary long-chain inulin (ITF IV) sup plementation mitigated 
the severity of AP: it suppressed characteristic inflammatory 
cell infiltration, modulated inflammatory cytokine production 
in the pancreatic–gut region, and prevented intestinal barrier 
function integrity. Its attenuating effect was associated with sup-
pression of AP-induced IRAK-4/p-JNK/NF-κB pathway activa-
tion. ITF I only demonstrated significant modulatory effects in 
colonic immune responses and serum inflammatory markers, 
suggesting that short-chain inulin effects are limited to the gut 
(Figure 6).
Inulin-type fructans have been tested in a variety of inflamma-
tory and immunological disease models and it has been shown 
that administration of ITF can exert immunomodulatory actions 
and alleviate acute inflammation (23, 28, 37). To the best of 
our knowledge, this is the first study in which efficacy of ITF is 
shown in AP. It has been earlier suggested, however, that dietary 
fibers are inversely related with pancreatic enzyme activity and 
can inhibit pancreatic digestive enzyme activities in  vivo (38). 
As premature activation of pancreatic zymogens is a triggering 
event of human AP and inhibited by ITF, this study supports the 
potential application of ITF in preventing AP.
A particular intriguing observation of this study was that 
long-chain inulins have a better local pancreatic and gut protec-
tive effect in AP than short-chain inulins. Previously, differential 
prebiotic and immunomodulatory effects have been demon-
strated by ITFs of varying chain length. Prolonged fermenta-
tion of long-chain inulin (DP > 10) compared with short-chain 
inulin (DP  <  10) ensures more endurable and profound 
prebiotic and immunomodulatory effects, locally in the colon 
and systemically in remote organs. Another ITF chain length-
dependent mechanism which might explain the difference is 
the magnitude by which ITFs can activate toll-like receptor 2, 
which is higher with long-chain than with short-chain ITFs 
(24). In addition, the preferential sites of fermentation for these 
two ITFs are different: colon for long-chain and small intestine 
for short-chain inulins. This may imply a prolonged and differ-
ent action of ITF IV as compared with ITF I and might explain 
the observation that ITF IV but not ITF I increased the colonic 
expression of the TJ proteins ZO-1 and occluding as well as 
AMP DEFB1 and CRAMP. Differential regulation of TJ pro-
teins has been observed after dietary interventions earlier (39).
Innate immune activations and pancreatic acinar cell inflam-
matory signaling are characteristic for AP (7). Moreover, AP 
induction by caerulein hyperstimulation caused neutrophil and 
FigUre 3 | Effects of ITF IV on AP-mediated neutrophil and macrophage infiltration and cytokines production in the pancreas. Mice were fed with 5% ITF I or ITF IV 
supplemented diets for 72 h before AP induction by caerulein. Neutrophil and macrophage infiltration and cytokine production in the pancreas were determined as 
described in Section “Materials and Methods,” respectively. Representative graphs showed dot plots of Ly-6G+CD11b+ neutrophils (a) and F4/80+CD11b+ 
macrophages (B) in the pancreas and quantitative analysis of neutrophils and macrophages infiltration (c). Quantitative analyses of TNF-α, IL-1β, and IL-10 levels in 
the pancreas were performed by ELISA (D). Data shown are means ± SEM. *P < 0.05 and ***P < 0.001. AP, acute pancreatitis; ELISA, enzyme-linked 
immunosorbent assay; IL, interleukin; ITF, inulin-type fructans; TNF-α, tumor necrosis factor-α.
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FigUre 4 | Effects of ITFs on neutrophil and macrophage infiltration and cytokine production in the colon. Mice were fed with 5% ITF I or ITF IV supplemented diets 
for 72 h before AP induction by caerulein. Neutrophil and macrophage infiltration and cytokine production in the colon were determined as described in Section 
“Materials and Methods,” respectively. Representative graphs showed dot plots of Ly-6G+CD11b+ neutrophils (a) and F4/80+CD11b+ macrophages (B) in the 
pancreas and quantitative analysis of neutrophils and macrophages infiltration in the colon (c). Quantitative analyses of TNF-α, IL-1β, and IL-10 levels in the colon 
were performed by ELISA (D). Data shown are means ± SEM. *P < 0.05, **P < 0.01, and ***P < 0.001. AP, acute pancreatitis; ELISA, enzyme-linked 
immunosorbent assay; IL, interleukin; ITF, inulin-type fructans; TNF-α, tumor necrosis factor-α.
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FigUre 5 | Continued
macrophage infiltration. This infiltration is prevented by dietary 
ITF IV supplementation. Increased pancreatic Ly6Chi monocytes/
macrophages have been found to be positively correlated with the 
severity of AP and are dependent on TNF-α production by these 
cells (11). IL-10 production by M2 macrophages has been shown 
to impair neutrophil recruitment in inflammatory and infectious 
conditions (40, 41). Along with reduced infiltration of neutrophils 
and macrophages in ITF IV-fed mice with AP, the production of 
TNF-α and IL-1β was found to be suppressed and IL-10 levels 
increased in pancreatic and colonic tissues. While modulatory 
effects of ITF IV were observed on pancreatic, colonic, and 
systemic cytokine levels, those of ITF I was only significant in 
FigUre 6 | ITF IV protection against AP by reducing pancreatic damage and AP-associated intestinal injury preventing its progression into a systemic inflammatory 
response. The role of ITF IV on AP in preventing tissues damage and the subsequent inflammatory responses was illustrated. AP, acute pancreatitis; ITF, inulin-type 
fructans.
FigUre 5 | Effects of ITFs on AP-mediated activation of MAPK and NF-κB pathways in the pancreas. Mice were fed with 5% ITF I or ITF IV supplemented diets for 
72 h before AP induction by caerulein. The activation/expression of pancreatic IRAK4 (a), p-TAK1 (B), p-ERK, p-JNK, p-p38 (c), and NF-κB p-p65 (D) were 
examined by Western blot. Data shown are means ± SEM. **P < 0.01 and ***P < 0.001. AP, acute pancreatitis; ERK, extracellular signal-regulated kinase; IRAK, 
IL-1 receptor associated kinase; ITF, inulin-type fructans; JNK, c-Jun N-terminal kinase; MAPKs, mitogen-activated protein kinases; NF-κB, nuclear factor 
kappa-light-chain-enhancer of activated B cells; TAK, TGF-β activated kinase.
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colonic and systemic cytokines. Balanced pro-inflammatory and 
anti-inflammatory cytokine production prevented an augmented 
inflammatory response from a positive inflammatory feedback 
circuit (42).
Pancreatic acinar inflammation with activation of MAPKs and 
of the transcription factor NF-κB is a key pathological event dur-
ing the development of AP (43–46). AP induction or supraphysi-
ological concentrations of caerulein are associated with MAPK 
activation in pancreatic acini (47). Overexpression of p65 protein 
trans-activated NF-κB aggravates acute pancreatic inflammatory 
responses and MAPKs regulate NF-κB activation by mediating 
phosphorylation of its inhibitory-κB IκB protein, to allow NF-κB 
translocation to the nucleus followed by upregulation of inflam-
matory genes (19, 47, 48). Here, we found that MAPKs JNK but not 
ERK1/2 or p38 activation was inhibited by ITF IV, concomitant 
with an attenuated NF-κB p65 nuclear translocation and activa-
tion. It might be speculated that different upstream MAPKs are 
regulated by dietary fibers. Our data suggest that ITF IV interferes 
with the development of AP, by reducing pancreatic activation of 
IRAK-4-JNK-NF-κB p65 signaling pathway and inhibiting the 
release of inflammatory mediators. It has been demonstrated that 
IRAK-4 has been demonstrated essential in many innate immune 
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responses and can activate JNK pathway and downstream NF-κB 
(20, 21, 49). NF-κB translocation in acinar cells increases the 
severity of pancreatitis in mice, and leads to transcription of 
cytokines and other inflammatory mediators (19). Our study 
shows that ITF IV downregulated IRAK-4/p-JNK/NF-κB p65 in 
the pancreas during AP.
As AP progresses, the inflammatory cytokines produced in 
the pancreas, including TNF-α and IL-1β, reach the gut by the 
microcirculation. These cytokines will recruit more leukocytes 
and induce more inflammatory mediators that ultimately will 
contribute to intestinal barrier dysfunction and mucosal injury 
(22, 50, 51). Gut barrier dysfunction and worsened gut perme-
ability in AP are accompanied by reduced expression of TJ 
reinforcing proteins and AMPs. Lack of physical and chemical 
barriers of the gut makes the host susceptible to bacterial translo-
cation that contributes to a second golf of inflammatory event in 
the pancreas, causing excessive inflammation and development 
of multi-organ dysfunctions. As shown here, dietary ITF IV 
intervention, by limiting pancreatic–gut inflammation, restoring 
gut barrier function and integrity to prevent secondary exces-
sive inflammatory responses, represents a promising approach 
to prevent the progress of AP. Although we have shown the 
modulatory effects of ITF IV on pancreatic–intestinal immunity 
and gut barrier function, the detailed mechanisms remain to be 
fully understood. Future investigation could identify specific 
receptor involvement and/or examine how their fermentation 
product SCFAs are regulated to exert protective effects during 
the condition. Moreover, the translational importance of these 
safe, value-added prebiotics for clinical AP merits further 
exploration.
Collectively, our data suggest that dietary ITF IV but not ITF 
I intake prevents the development of AP by three-graded actions: 
first, by preventing pancreatic inflammation and damage; second, 
by preventing AP-associated intestinal barrier dysfunction and 
intestinal inflammation; and last, by precluding progression of 
the gut and pancreatic inflammation into a systemic inflam-
matory response by the two aforementioned mechanisms. The 
current study provides evidence that nutritional application of 
long-chain inulins in clinical AP might be efficacious.
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FigUre s1 | Effects of dietary ITF supplementation on markers of pancreatic 
damage. Mice were fed with 5% ITF I or 5% ITF IV supplemented diets for 72 h. 
Serum amylase (a), pancreatic MPO activity (B), and pancreatic edema (c) were 
then determined as described in Section “Materials and Methods,” respectively. 
Data shown are means ± SEM. ITF, inulin-type fructans; MPO, myeloperoxidase.
FigUre s2 | Effects of ITF IV on CD8a+ DCs in the pancreas during AP: 
representative flow cytometry dot plots of CD11c+MHCII+ DCs (a), histogram 
(B), and percentage (c) of CD8a+ DCs on DC subsets in the pancreas were 
shown. Data shown are means ± SEM from four independent experiments with 
three to four pooled mice per group in each experiment. **P < 0.01. AP, acute 
pancreatitis; DCs, dendritic cells; ITF, inulin-type fructans.
FigUre s3 | Effects of ITF IV on CD8a+ DCs in the colon during AP: 
representative flow cytometer dot plots of CD11c+MHCII+ DCs (a), histogram 
(B), and percentage (c) of CD8a+ DCs on DC subsets in the colon were shown. 
Data shown are means ± SEM from four independent experiments with three to 
four pooled mice per group in each experiment. *P < 0.05 and **P < 0.01. AP, 
acute pancreatitis; DCs, dendritic cells; ITF, inulin-type fructans.
reFerences
1. Lankisch PG, Apte M, Banks PA. Acute pancreatitis. Lancet (2015) 386:85–96. 
doi:10.1016/S0140-6736(14)60649-8 
2. Sun Y, He Y, Wang F, Zhang H, de Vos P, Sun J. Low-methoxyl lemon pectin 
attenuates inflammatory responses and improves intestinal barrier integrity in 
caerulein-induced experimental acute pancreatitis. Mol Nutr Food Res (2017) 
61(4). doi:10.1002/mnfr.201600885 
3. Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG, et al. 
Classification of acute pancreatitis – 2012: revision of the Atlanta classification 
and definitions by international consensus. Gut (2013) 62:102–11. doi:10.1136/
gutjnl-2012-302779 
4. Janisch N, Gardner T. Recent advances in managing acute pancreatitis. F1000Res 
(2015) 4:F1000 Faculty Rev–1474. doi:10.12688/f1000research.7172.1 
5. Shamoon M, Deng Y, Chen YQ, Bhatia M, Sun J. Therapeutic implications of 
innate immune system in acute pancreatitis. Expert Opin Ther Targets (2016) 
20:73–87. doi:10.1517/14728222.2015.1077227 
6. Zheng L, Xue J, Jaffee EM, Habtezion A. Role of immune cells and immune-
based therapies in pancreatitis and pancreatic ductal adenocarcinoma. 
Gastroenterology (2013) 144:1230–40. doi:10.1053/j.gastro.2012.12.042 
13
He et al. Long-Chain Inulins Modulate Acute Pancreatitis
Frontiers in Immunology | www.frontiersin.org September 2017 | Volume 8 | Article 1209
7. Watanabe T, Kudo M, Strober W. Immunopathogenesis of pancreatitis. 
Mucosal Immunol (2017) 10:283–98. doi:10.1038/mi.2016.101 
8. Mayer J, Rau B, Gansauge F, Beger HG. Inflammatory mediators in human 
acute pancreatitis: clinical and pathophysiological implications. Gut (2000) 
47:546–52. doi:10.1136/gut.47.4.546 
9. Sun J, Bhatia M. Blockade of neurokinin-1 receptor attenuates CC and CXC 
chemokine production in experimental acute pancreatitis and associated 
lung injury. Am J Physiol Gastrointest Liver Physiol (2007) 292:G143–53. 
doi:10.1152/ajpgi.00271.2006 
10. Juss JK, House D, Amour A, Begg M, Herre J, Storisteanu DM, et al. Acute 
respiratory distress syndrome neutrophils have a distinct phenotype and are 
resistant to phosphoinositide 3-kinase inhibition. Am J Respir Crit Care Med 
(2016) 194:961–73. doi:10.1164/rccm.201509-1818OC 
11. Perides G, Weiss ER, Michael ES, Laukkarinen JM, Duffield JS, Steer ML. 
TNF-alpha-dependent regulation of acute pancreatitis severity by Ly-6C(hi) 
monocytes in mice. J Biol Chem (2011) 286:13327–35. doi:10.1074/jbc.
M111.218388 
12. Bonjoch L, Gea-Sorli S, Closa D. Lipids generated during acute pancreatitis 
increase inflammatory status of macrophages by interfering with their M2 
polarization. Pancreatology (2015) 15:352–9. doi:10.1016/j.pan.2015.04.007 
13. Bedrosian AS, Nguyen AH, Hackman M, Connolly MK, Malhotra A, 
Ibrahim J, et  al. Dendritic cells promote pancreatic viability in mice with 
acute pancreatitis. Gastroenterology (2011) 141:1915–26.e1–14. doi:10.1053/j.
gastro.2011.07.033 
14. Ishibashi T, Zhao H, Kawabe K, Oono T, Egashira K, Suzuki K, et al. Blocking 
of monocyte chemoattractant protein-1 (MCP-1) activity attenuates the sever-
ity of acute pancreatitis in rats. J Gastroenterol (2008) 43:79–85. doi:10.1007/
s00535-007-2126-9 
15. Denham W, Yang J, Fink G, Denham D, Carter G, Ward K. Gene targeting 
demonstrates additive detrimental effects of interleukin 1 and tumor necrosis 
factor during pancreatitis. Gastroenterology (1997) 113:1741–6. doi:10.1053/
gast.1997.v113.pm9352880 
16. Saraiva M, O’Garra A. The regulation of IL-10 production by immune cells. 
Nat Rev Immunol (2010) 10:170–81. doi:10.1038/nri2711 
17. Frossard JL, Steer ML, Pastor CM. Acute pancreatitis. Lancet (2008) 
371:143–52. doi:10.1016/S0140-6736(08)60107-5 
18. Van Laethem JL, Eskinazi R, Louis H, Rickaert F, Robberecht P, Deviere J. 
Multisystemic production of interleukin 10 limits the severity of acute pancre-
atitis in mice. Gut (1998) 43:408–13. doi:10.1136/gut.43.3.408 
19. Huang H, Liu Y, Daniluk J, Gaiser S, Chu J, Wang H, et al. Activation of nuclear 
factor-kappaB in acinar cells increases the severity of pancreatitis in mice. 
Gastroenterology (2013) 144:202–10. doi:10.1053/j.gastro.2012.09.059 
20. Suzuki N, Suzuki S, Duncan GS, Millar DG, Wada T, Mirtsos C, et al. Severe 
impairment of interleukin-1 and toll-like receptor signalling in mice lacking 
IRAK-4. Nature (2002) 416:7. doi:10.1038/nature736 
21. Li S, Strelow A, Fontana EJ, Wesche H. IRAK-4: a novel member of the IRAK 
family with the properties of an IRAK-kinase. Proc Natl Acad Sci U S A (2002) 
99:5567–72. doi:10.1073/pnas.082100399 
22. Capurso G, Zerboni G, Signoretti M, Valente R, Stigliano S, Piciucchi M, 
et al. Role of the gut barrier in acute pancreatitis. J Clin Gastroenterol (2012) 
46(Suppl):S46–51. doi:10.1097/MCG.0b013e3182652096 
23. Chen K, Chen H, Faas MM, de Haan BJ, Li J, Xiao P, et al. Specific inulin-type 
fructan fibers protect against autoimmune diabetes by modulating gut immu-
nity, barrier function, and microbiota homeostasis. Mol Nutr Food Res (2017) 
61(8). doi:10.1002/mnfr.201601006 
24. Vogt L, Ramasamy U, Meyer D, Pullens G, Venema K, Faas MM, et al. Immune 
modulation by different types of β2→1-fructans is toll-like receptor depen-
dent. PLoS One (2013) 8:e68367. doi:10.1371/journal.pone.0068367 
25. Bermudez-Brito M, Sahasrabudhe NM, Rosch C, Schols HA, Faas MM, de Vos P. 
The impact of dietary fibers on dendritic cell responses in vitro is dependent 
on the differential effects of the fibers on intestinal epithelial cells. Mol Nutr 
Food Res (2015) 59:698–710. doi:10.1002/mnfr.201400811 
26. Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R, Rowland I, 
et  al. Prebiotic effects: metabolic and health benefits. Br J Nutr (2010) 
104(Suppl 2):S1–63. doi:10.1017/S0007114510003363 
27. Ito H, Takemura N, Sonoyama K, Kawagishi H, Topping DL, Conlon MA, et al. 
Degree of polymerization of inulin-type fructans differentially affects number 
of lactic acid bacteria, intestinal immune functions, and immunoglobulin A 
secretion in the rat cecum. J Agric Food Chem (2011) 59:5771–8. doi:10.1021/
jf200859z 
28. Vogt L, Meyer D, Pullens G, Faas M, Smelt M, Venema K, et al. Immunological 
properties of inulin-type fructans. Crit Rev Food Sci Nutr (2015) 55:414–36. 
doi:10.1080/10408398.2012.656772 
29. Vogt LM, Elderman ME, Borghuis T, de Haan BJ, Faas MM, de Vos P. Chain 
length-dependent effects of inulin-type fructan dietary fiber on human 
systemic immune responses against hepatitis-B. Mol Nutr Food Res (2017). 
doi:10.1002/mnfr.201700171 
30. Deng YY, Shamoon M, He Y, Bhatia M, Sun J. Cathelicidin-related antimicro-
bial peptide modulates the severity of acute pancreatitis in mice. Mol Med Rep 
(2016) 13:3881–5. doi:10.3892/mmr.2016.5008 
31. Barbeiro DF, Koike MK, Coelho AM, da Silva FP, Machado MC. Intestinal 
barrier dysfunction and increased COX-2 gene expression in the gut of elderly 
rats with acute pancreatitis. Pancreatology (2016) 16:52–6. doi:10.1016/j.
pan.2015.10.012 
32. Hilchie AL, Wuerth K, Hancock REW. Immune modulation by multifaceted 
cationic host defense (antimicrobial) peptides. Nat Chem Biol (2013) 9:761–8. 
doi:10.1038/nchembio.1393 
33. Cheng M, Ho S, Yoo JH, Tran DH, Bakirtzi K, Su B, et  al. Cathelicidin 
suppresses colon cancer development by inhibition of cancer associated 
fibroblasts. Clin Exp Gastroenterol (2015) 8:13–29. doi:10.2147/CEG.S70906 
34. Gukovskaya AS, Vaquero E, Zaninovic V, Gorelick FS, Lusis AJ, 
Brennan ML, et al. Neutrophils and NADPH oxidase mediate intrapancreatic 
trypsin activation in murine experimental acute pancreatitis. Gastroenterology 
(2002) 122:974–84. doi:10.1053/gast.2002.32409 
35. Abdulla A, Awla D, Thorlacius H, Regner S. Role of neutrophils in the 
activation of trypsinogen in severe acute pancreatitis. J Leukoc Biol (2011) 
90:975–82. doi:10.1189/jlb.0411195 
36. Shrivastava P, Bhatia M. Essential role of monocytes and macrophages in 
the progression of acute pancreatitis. World J Gastroenterol (2010) 16:3995. 
doi:10.3748/wjg.v16.i32.3995 
37. Osman N, Adawi D, Molin G, Ahrne S, Berggren A, Jeppsson B. Bifidobacterium 
infantis strains with and without a combination of oligofructose and 
inulin (OFI) attenuate inflammation in DSS-induced colitis in rats. BMC 
Gastroenterol (2006) 6:31. doi:10.1186/1471-230X-6-31 
38. Dutta SK, Hlasko J. Dietary fiber in pancreatic disease: effect of high fiber 
diet on fat malabsorption in pancreatic insufficiency and in vitro study of the 
interaction of dietary fiber with pancreatic enzymes. Am J Clin Nutr (1985) 
41:517–25. 
39. Patel RM, Myers LS, Kurundkar AR, Maheshwari A, Nusrat A, Lin PW. Probiotic 
bacteria induce maturation of intestinal claudin 3 expression and barrier 
function. Am J Pathol (2012) 180:626–35. doi:10.1016/j.ajpath.2011.10.025 
40. Andrade EB, Alves J, Madureira P, Oliveira L, Ribeiro A, Cordeiro-da-Silva A, 
et  al. TLR2-induced IL-10 production impairs neutrophil recruitment to 
infected tissues during neonatal bacterial sepsis. J Immunol (2013) 191:4759–
68. doi:10.4049/jimmunol.1301752 
41. Sun L, Guo RF, Newstead MW, Standiford TJ, Macariola DR, Shanley TP. 
Effect of IL-10 on neutrophil recruitment and survival after Pseudomonas 
aeruginosa challenge. Am J Respir Cell Mol Biol (2009) 41:76–84. doi:10.1165/
rcmb.2008-0202OC 
42. Gea-Sorli S, Closa D. In vitro, but not in vivo, reversibility of peritoneal mac-
rophages activation during experimental acute pancreatitis. BMC Immunol 
(2009) 10:42. doi:10.1186/1471-2172-10-42 
43. Sah RP, Garg P, Saluja AK. Pathogenic mechanisms of acute pancreatitis. Curr 
Opin Gastroenterol (2012) 28:507–15. doi:10.1097/MOG.0b013e3283567f52 
44. Dong Z, Shang H, Chen YQ, Pan LL, Bhatia M, Sun J. Sulforaphane protects 
pancreatic acinar cell injury by modulating Nrf2-mediated oxidative stress and 
NLRP3 inflammatory pathway. Oxid Med Cell Longev (2016) 2016:7864150. 
doi:10.1155/2016/7864150 
45. Ramnath RD, Sun J, Adhikari S, Bhatia M. Effect of mitogen-activated 
protein kinases on chemokine synthesis induced by substance P in mouse 
pancreatic acinar cells. J Cell Mol Med (2007) 11:1326–41. doi:10.1111/j. 
1582-4934.2007.00086.x 
46. Kanak MA, Shahbazov R, Yoshimatsu G, Levy MF, Lawrence MC, Naziruddin B. 
A small molecule inhibitor of NFkappaB blocks ER stress and the NLRP3 
inflammasome and prevents progression of pancreatitis. J Gastroenterol 
(2017) 52:352–65. doi:10.1007/s00535-016-1238-5 
14
He et al. Long-Chain Inulins Modulate Acute Pancreatitis
Frontiers in Immunology | www.frontiersin.org September 2017 | Volume 8 | Article 1209
47. Koh YH, Tamizhselvi R, Bhatia M. Extracellular signal-regulated kinase 1/2 
and c-Jun NH2-terminal kinase, through nuclear factor-kappaB and activator 
protein-1, contribute to caerulein-induced expression of substance P and 
neurokinin-1 receptors in pancreatic acinar cells. J Pharmacol Exp Ther (2010) 
332:940–8. doi:10.1124/jpet.109.160416 
48. Algul H, Treiber M, Lesina M, Nakhai H, Saur D, Geisler F, et al. Pancreas-
specific RelA/p65 truncation increases susceptibility of acini to inflamma-
tion-associated cell death following cerulein pancreatitis. J Clin Invest (2007) 
117:1490–501. doi:10.1172/JCI29882 
49. Sun J, Wiklund F, Hsu FC, Bälter K, Zheng SL, Johansson JE, et al. Interactions 
of sequence variants in interleukin-1 receptor-associated kinase4 and the toll-
like receptor 6-1-10 gene cluster increase prostate cancer risk. Cancer Epide-
miol Biomarkers Prev (2006) 15:480–5. doi:10.1158/1055-9965.EPI-05-0645 
50. Gunjaca I, Zunic J, Gunjaca M, Kovac Z. Circulating cytokine levels in acute 
pancreatitis-model of SIRS/CARS can help in the clinical assessment of dis-
ease severity. Inflammation (2012) 35:758–63. doi:10.1007/s10753-011-9371-z 
51. Machado MC, da Silva FP, Cunha DG, Barbeiro DF, Coelho AMM, Souza HP. 
Tu1915 intestinal barrier dysfunction in ageing animals with acute pancreati-
tis: increased intestinal inflammation? Gastroenterology (2015) 148:S–1190. 
doi:10.1016/S0016-5085(15)34066-X 
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be 
construed as a potential conflict of interest.
Copyright © 2017 He, Wu, Li, Li, Sun, Zhang, de Vos, Pan and Sun. This is 
an open-access article distributed under the terms of the Creative Commons 
Attribution License (CC BY). The use, distribution or reproduction in other forums 
is permitted, provided the original author(s) or licensor are credited and that the 
original publication in this journal is cited, in accordance with accepted academic 
practice. No use, distribution or reproduction is permitted which does not comply 
with these terms.
